Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bayes-Genis

Showing results (361-370 of 645) with videos related to

Pageof 65
Sort By:
Journal of Cardiac Failure|December 3, 2014
ST2 pathogenetic profile in ambulatory heart failure patientsAntoni Bayes-Genis, James L Januzzi, Hanna K Gaggin, et al.
Journal of Molecular and Cellular Cardiology|April 19, 2019
Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarctionM C Asensio-Lopez, A Lax, M J Fernandez Del Palacio, et al.
European Heart Journal. Acute Cardiovascular Care|September 4, 2018
Growth differentiation factor-15 is a predictive biomarker in primary ventricular fibrillation: The RUTI-STEMI-PVF studyC Garcia-Garcia, F Rueda, J Lupon, et al.
International Journal of Cardiology|January 1, 2019
Trends in prevalence and outcomes of acute coronary syndrome associated with cocaine consumption: The RUTI-cocaine studyXavier Carrillo, Victoria Vilalta, German Cediel, et al.
Circulation. Heart Failure|March 24, 2012
Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formulaFinlay A McAlister, Justin Ezekowitz, Luigi Tarantini, et al.
European Journal of Heart Failure|September 27, 2017
Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalizationJosep Lupón, Joanne Simpson, John J V McMurray, et al.
Revista Espanola De Cardiologia (English Ed.)|March 11, 2017
Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart FailureAntoni Bayes-Genis, Jaume Barallat, Marta de Antonio, et al.
Scientific Reports|March 16, 2021
The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizationsJulio Núñez, Eduardo Núñez, Elena Revuelta-López, et al.
Echocardiography (Mount Kisco, N.Y.)|November 30, 2021
Prevalence and factors associated with atrial mitral and tricuspid regurgitation in patients with atrial fibrillationFrancisco Gual-Capllonch, Germán Cediel, Albert Teis, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|June 12, 2019
New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology-voltage-P-wave duration)Bryce Alexander, Julia Milden, Bachar Hazim, et al.
Pageof 65

Showing results (361-370 of 645) with videos related to

Sort By:
Pageof 65
Journal of Cardiac Failure|December 3, 2014
ST2 pathogenetic profile in ambulatory heart failure patientsAntoni Bayes-Genis, James L Januzzi, Hanna K Gaggin, et al.
Journal of Molecular and Cellular Cardiology|April 19, 2019
Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarctionM C Asensio-Lopez, A Lax, M J Fernandez Del Palacio, et al.
European Heart Journal. Acute Cardiovascular Care|September 4, 2018
Growth differentiation factor-15 is a predictive biomarker in primary ventricular fibrillation: The RUTI-STEMI-PVF studyC Garcia-Garcia, F Rueda, J Lupon, et al.
International Journal of Cardiology|January 1, 2019
Trends in prevalence and outcomes of acute coronary syndrome associated with cocaine consumption: The RUTI-cocaine studyXavier Carrillo, Victoria Vilalta, German Cediel, et al.
Circulation. Heart Failure|March 24, 2012
Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formulaFinlay A McAlister, Justin Ezekowitz, Luigi Tarantini, et al.
European Journal of Heart Failure|September 27, 2017
Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalizationJosep Lupón, Joanne Simpson, John J V McMurray, et al.
Revista Espanola De Cardiologia (English Ed.)|March 11, 2017
Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart FailureAntoni Bayes-Genis, Jaume Barallat, Marta de Antonio, et al.
Scientific Reports|March 16, 2021
The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizationsJulio Núñez, Eduardo Núñez, Elena Revuelta-López, et al.
Echocardiography (Mount Kisco, N.Y.)|November 30, 2021
Prevalence and factors associated with atrial mitral and tricuspid regurgitation in patients with atrial fibrillationFrancisco Gual-Capllonch, Germán Cediel, Albert Teis, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|June 12, 2019
New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology-voltage-P-wave duration)Bryce Alexander, Julia Milden, Bachar Hazim, et al.
Pageof 65